Michael J. Greenall
About
In The Last Decade
Michael J. Greenall
52 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 1.6k
- Oncology 1.5k
- Cancer Research 993
- Surgery 786
- Immunology 724
Countries citing papers authored by Michael J. Greenall
This map shows the geographic impact of Michael J. Greenall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Greenall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Greenall more than expected).
Fields of papers citing papers by Michael J. Greenall
This network shows the impact of papers produced by Michael J. Greenall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Greenall. The network helps show where Michael J. Greenall may publish in the future.
Co-authorship network of co-authors of Michael J. Greenall
This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Greenall. A scholar is included among the top collaborators of Michael J. Greenall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Greenall. Michael J. Greenall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 11 | |
| 3 | 49 | |
| 4 | 111 | |
| 5 | 2 | |
| 6 | 76 | |
| 7 | 41 | |
| 8 | 25 | |
| 9 | 4 | |
| 10 | 143 | |
| 11 | 143 | |
| 12 | 44 | |
| 13 | Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. | 80 |
| 14 | Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity. | 103 |
| 15 | Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer breakdown → | 697 |
| 16 | 24 | |
| 17 | Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. | 80 |
| 18 | 6 | |
| 19 | 8 | |
| 20 | 97 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.